Skip to main content

Table 3 Changes in MOS-HIV subscale scores over time

From: Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study

 

Baseline

(n = 207)

Week 4

(n = 207)

Week 24

(n = 188)

Week 48

(n = 177)

General health perceptions

53.3 (1.5)

59.5 (1.4)

66.2 (1.3)

66.9 (1.4)

Pain

71.9 (1.9)

82.4 (1.4)

82.1 (1.6)

66.3 (1.8)

Physical functioning

90.7 (1.0)

93.1 (0.8)

94.1 (0.9)

94.3 (0.8)

Role functioning

79.5 (2.5)

87.3 (2.1)

89.8 (2.0)

90.6 (2.0)

Social functioning

83.4 (1.6)

87.0 (1.3)

89.3 (1.2)

90.7 (1.2)

Energy / Fatigue

47.2 (0.9)

47.0 (0.9)

45.2 (0.9)

46.1 (0.8)

Mental health

63.2 (1.5)

69.9 (1.3)

73.5 (1.4)

72.2 (1.5)

Health distress

62.6 (1.9)

72.9 (1.7)

76.0 (1.6)

76.0 (1.7)

Cognitive function

72.8 (1.5)

78.8 (1.3)

77.7 (1.4)

78.2 (1.4)

Quality of life

46.5 (1.5)

55.3 (1.5)

59.9 (1.4)

61.1 (1.5)

Health transition

54.6 (1.5)

60.2 (1.3)

57.9 (1.3)

61.1 (1.5)

  1. Data are expressed as the mean (standard error)
  2. MOS-HIV Medical Outcomes Study Human Immunodeficiency Virus Health Survey